Citations (24)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (2)
Ning Wang, Wei-Wei Li, Jian-Ping Li, Juan-Yue Liu, Yong-Chun Zhou, Ying Zhang, Jing Hu, Yan-Hong Huang, Yan Chen, Li-Chun Wei & Mei Shi. (2014) Comparison of concurrent chemoradiotherapy followed by radical surgery and high-dose-rate intracavitary brachytherapy: a retrospective study of 240 patients with FIGO stage IIB cervical carcinoma. OncoTargets and Therapy 7, pages 91-100.
Read now
Read now
Rob Lukas, Robova Helena, Halaska Michael Jiri, Hruda Martin & Skapa Petr. (2013) Current status of sentinel lymph node mapping in the management of cervical cancer. Expert Review of Anticancer Therapy 13:7, pages 861-870.
Read now
Read now
Articles from other publishers (22)
Jiangchun Wu, Qinhao Guo, Jun Zhu, Yong Wu, Simin Wang, Siyuan Liang, Xingzhu Ju & Xiaohua Wu. (2023) Developing a nomogram for preoperative prediction of cervical cancer lymph node metastasis by multiplex immunofluorescence. BMC Cancer 23:1.
Crossref
Crossref
Graziella Moufawad, Antonio Simone Laganà, Nassir Habib, Vito Chiantera, Andrea Giannini, Federico Ferrari, Amerigo Vitagliano, Luigi Della Corte, Giuseppe Bifulco & Zaki Sleiman. (2023) Learning Laparoscopic Radical Hysterectomy: Are We Facing an Emerging Situation?. International Journal of Environmental Research and Public Health 20:3, pages 2053.
Crossref
Crossref
Raluca Tulin, Iulian Slavu, Constantin Oprescu, Anca Macovei Oprescu, Dana Paula Venter, Cornelia Niţipir & Adrian Tulin. (2022) Radical hysterectomy for locally advanced cervical cancer with Para-Aortic lymphadenectomy: case presentation. Romanian Journal of Orthopaedic Surgery and Traumatology 5:1, pages 7-11.
Crossref
Crossref
Rui Liu, Yanan Ma, Wenli Gu, Canxu Song, Lina Zhou, Huanran Meng, Yuan Zhang & Caihong Yang. (2022) RNA interference-mediated knockdown of tripartite motif containing 44 suppresses cervical cancer growth in vitro and in vivo. Molecular & Cellular Toxicology.
Crossref
Crossref
Shinya Matsuzaki, Maximilian Klar, Mikio Mikami, Muneaki Shimada, Brendan H. Grubbs, Keiichi Fujiwara, Lynda D. Roman & Koji Matsuo. (2020) Management of Stage IIB Cervical Cancer: an Overview of the Current Evidence. Current Oncology Reports 22:3.
Crossref
Crossref
Mika Okazawa-Sakai, Takanori Yokoyama, Etsuko Fujimoto, Shinichi Okame, Yuko Shiroyama, Takashi Yokoyama & Kazuhiro Takehara. (2018) Long-term outcomes of postoperative taxane/platinum chemotherapy for early stage cervical cancer: a retrospective study. International Journal of Clinical Oncology 23:4, pages 715-725.
Crossref
Crossref
Chia-Chun Li, Ting-Chang Chang, Yun-Fang Tsai & Lynn Chen. (2017) Quality of life among survivors of early-stage cervical cancer in Taiwan: an exploration of treatment modality differences. Quality of Life Research 26:10, pages 2773-2782.
Crossref
Crossref
Benoîte Méry, Sylvie Mengue Ndong, Jean-Baptiste Guy, Avi Assouline, Alexander T. Falk, Anaïs Valeille, Jane-Chloé Trone, Romain Rivoirard, Pierre Auberdiac, Alexis Vallard, Sophie Espenel, Guillaume Moriceau, Olivier Collard, Claire Bosacki, Jean-Philippe Jacquin, Guy de Laroche, Pierre Fournel, Cyrus Chargari & Nicolas Magné. (2016) Radiotherapy for gynecologic cancer in nonagenarian patients: a framework for new paradigms. Chinese Journal of Cancer 35:1.
Crossref
Crossref
Yih-Lin Chung, Cheng-Fang Horng, Pei-Ing Lee & Fong-Lin Chen. (2016) Patterns of failure after use of 18F-FDG PET/CT in integration of extended-field chemo-IMRT and 3D-brachytherapy plannings for advanced cervical cancers with extensive lymph node metastases. BMC Cancer 16:1.
Crossref
Crossref
Jienan Kong, Chunchan Di, Junjie Piao, Jie Sun, Longzhe Han, Liyan Chen, Guanghai Yan & Zhenhua Lin. (2016) Ezrin contributes to cervical cancer progression through induction of epithelial-mesenchymal transition. Oncotarget 7:15, pages 19631-19642.
Crossref
Crossref
Jianbo Yang, Chao Ding, Tenghui Zhang, Liang Zhang, Tengfei Lv, Xiaolong Ge, Jianfeng Gong, Weiming Zhu, Ning Li & Jieshou Li. (2015) Clinical features, outcome and risk factors in cervical cancer patients after surgery for chronic radiation enteropathy. Radiation Oncology 10:1.
Crossref
Crossref
ShanShan Yang, Ying Gao, Jing Sun, Bairong Xia, TianBo Liu, HongXia Zhang, Qi Li, Min Xiao & YunYan Zhang. (2015) Neoadjuvant chemotherapy followed by radical surgery as an alternative treatment to concurrent chemoradiotherapy for young premenopausal patients with FIGO stage IIB squamous cervical carcinoma. Tumor Biology 36:6, pages 4349-4356.
Crossref
Crossref
Lukas Rob. 2015. Pelvic Cancer Surgery. Pelvic Cancer Surgery
367
375
.
Yanlan Chai, Tao Wang, Juan Wang, Yunyi Yang, Ying Gao, Jiyong Gao, Shangfeng Gao, Yueling Wang, Xi Zhou & Zi Liu. (2014) Radical hysterectomy with adjuvant radiotherapy versus radical radiotherapy for FIGO stage IIB cervical cancer. BMC Cancer 14:1.
Crossref
Crossref
Ming-Mo Hou, Xiaochun Liu, Jennifer Wheler, Aung Naing, David Hong, Robert L. Coleman, Apostolia Tsimberidou, Filip Janku, Ralph Zinner, Karen Lu, Razelle Kurzrock & Siqing Fu. (2014) Targeted PI3K/AKT/mTOR therapy for metastatic carcinomas of the cervix: A phase I clinical experience. Oncotarget 5:22, pages 11168-11179.
Crossref
Crossref
Chin-Hui Wu, An-Cheng Shiau, Yi-Jen Liao, Hsin-Yu Lin, Yen-Wan Hsueh Liu & Shih-Ming Hsu. (2014) Influence of Metal of the Applicator on the Dose Distribution during Brachytherapy. PLoS ONE 9:8, pages e104831.
Crossref
Crossref
Mika Okazawa, Seiji Mabuchi, Fumiaki Isohashi, Osamu Suzuki, Yasuo Yoshioka, Tomoyuki Sasano, Yukinobu Ohta, Shoji Kamiura, Kazuhiko Ogawa & Tadashi Kimura. (2013) Impact of the Addition of Concurrent Chemotherapy to Pelvic Radiotherapy in Surgically Treated Stage IB1-IIB Cervical Cancer Patients With Intermediate-Risk or High-Risk Factors: A 13-Year Experience. International Journal of Gynecologic Cancer 23:3, pages 567-575.
Crossref
Crossref
Surbhi Grover, Shayna Showalter, Kate H. Kraft, Gita Suneja & Lilie Lin. (2013) The Impact of Race and Partner Status on Patterns of Care and Survival in Young Women With Early-Stage Cervical Cancer. International Journal of Gynecologic Cancer 23:3, pages 494-499.
Crossref
Crossref
Pierre Loubeyre, Isabelle Navarria, Manuela Undurraga, Alexandre Bodmer, Osman Ratib, Christoph Becker & Patrick Petignat. (2012) Is imaging relevant for treatment choice in early stage cervical uterine cancer?. Surgical Oncology 21:1, pages e1-e6.
Crossref
Crossref
Seiji Mabuchi, Mika Okazawa, Fumiaki Isohashi, Koji Matsuo, Yukinobu Ohta, Osamu Suzuki, Yasuo Yoshioka, Takayuki Enomoto, Shoji Kamiura & Tadashi Kimura. (2011) Radical hysterectomy with adjuvant radiotherapy versus definitive radiotherapy alone for FIGO stage IIB cervical cancer. Gynecologic Oncology 123:2, pages 241-247.
Crossref
Crossref
László Ungár, László Pálfalvi, László Tarnai, Dániel Horányi & Zoltán Novák. (2011) Surgical treatment of lymph node metastases in stage IB cervical cancer. The laterally extended parametrectomy (LEP) procedure: Experience with a 5year follow-up. Gynecologic Oncology 123:2, pages 337-341.
Crossref
Crossref
Kenji Yoshida, Ryohei Sasaki, Hideki Nishimura, Daisuke Miyawaki, Tetsuya Kawabe, Yoshiaki Okamoto, Koji Nakabayashi, Shigeki Yoshida & Kazuro Sugimura. (2010) Radiotherapy for Japanese elderly patients with cervical cancer: preliminary survival outcomes and evaluation of treatment-related toxicity. Archives of Gynecology and Obstetrics 284:4, pages 1007-1014.
Crossref
Crossref